What are the main threats to graft survival?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Main Threats to Graft Survival

The three primary threats to graft survival are infection (particularly Pseudomonas aeruginosa), hematoma formation, and mechanical factors including shear stress and displacement.

Infection as the Leading Threat

Infection represents the most significant threat to graft survival, accounting for approximately 23.5% of all graft losses in general plastic surgery populations 1.

  • Pseudomonas aeruginosa is the most dangerous pathogen, responsible for 58.1% of infection-related graft failures and causing more fulminant infections with 4.2 times higher reoperation rates compared to other organisms 1.
  • Staphylococcus aureus, Enterobacter, enterococci, and Acinetobacter are secondary infectious threats 1.
  • Infection risk varies dramatically by wound type: vascular ulcers (58.3% graft loss) and burns (47.4% graft loss) carry significantly higher infection-related failure rates compared to traumatic defects (16.7%) or donor sites (13.5%) 1.
  • Full-thickness grafts demonstrate superior resistance to infection compared to split-thickness grafts 1.
  • Lower extremity grafts and multiple-site applications face elevated infection risk 1.

Hematoma Formation

Hematoma represents a common and preventable cause of graft failure through multiple mechanisms 2.

  • Hematomas trigger massive neutrophil accumulation (177.43 ± 22.464 neutrophils in hematoma groups), which inversely correlates with graft survival 2.
  • The mechanical barrier created by blood collection prevents graft adherence and vascular ingrowth 2.
  • Graft survival drops precipitously to approximately 20% when significant hematoma develops 2.
  • Prevention is critical: hemostatic agents like microporous polysaccharide hemospheres can improve baseline graft survival to 97.86% by reducing neutrophil infiltration 2.

Mechanical Factors: Shear Stress and Displacement

Shear stress and movement compromise graft survival through hemodynamic and physical disruption 3.

  • Acute-phase shear stress from transient portal hypertension damages small grafts, particularly in solid organ transplantation 3.
  • Excessive blood flow and mechanical forces disrupt sinusoidal integrity and graft architecture 3.
  • Movement and displacement prevent the critical early vascular anastomosis between graft and wound bed 2.
  • Proper immobilization during the first 5 days post-grafting is essential for successful integration 2.

Seroma

While seromas are documented as minor complications in graft procedures, they represent a lesser threat compared to hematomas and infections 4.

  • Seromas occur less frequently and with lower morbidity than hematomas 4.
  • They primarily pose risk through creating fluid collections that prevent graft adherence, similar to but less severe than hematomas 4.

Clinical Pitfall

The most critical error is underestimating Pseudomonas risk in high-risk wounds (vascular ulcers and burns), where aggressive preoperative wound bed preparation and consideration of prophylactic anti-pseudomonal coverage may be warranted 1.

References

Research

Preventing graft loss caused by hematoma: experimental study.

Journal of burn care & research : official publication of the American Burn Association, 2014

Research

Attenuation of acute phase shear stress by somatostatin improves small-for-size liver graft survival.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.